An open trial of buspirone in the treatment of attention-deficit disorder.
about
Mechanism-based pharmacokinetic/pharmacodynamic modeling of rat prefrontal cortical dopamine response to dual acting norepinephrine reuptake inhibitor and 5-HT1A partial agonist.Adult ADHD and substance abuse: diagnostic and treatment issues.Pharmacokinetic evaluation of eltoprazine.Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range.
P2860
An open trial of buspirone in the treatment of attention-deficit disorder.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
An open trial of buspirone in the treatment of attention-deficit disorder.
@en
An open trial of buspirone in the treatment of attention-deficit disorder.
@nl
type
label
An open trial of buspirone in the treatment of attention-deficit disorder.
@en
An open trial of buspirone in the treatment of attention-deficit disorder.
@nl
prefLabel
An open trial of buspirone in the treatment of attention-deficit disorder.
@en
An open trial of buspirone in the treatment of attention-deficit disorder.
@nl
P356
P1476
An open trial of buspirone in the treatment of attention-deficit disorder.
@en
P2093
Helmut Niederhofer
P2860
P304
P356
10.1002/HUP.511
P577
2003-08-01T00:00:00Z